Suzhou Zelgen Biopharmaceuticals Co., Ltd. Depreciation And Amortization for the year ending December 31, 2024: USD 7.61 M

Suzhou Zelgen Biopharmaceuticals Co., Ltd. Depreciation And Amortization is USD 7.61 M for the year ending December 31, 2024, a -1.40% change year over year. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.
  • Suzhou Zelgen Biopharmaceuticals Co., Ltd. Depreciation And Amortization for the year ending December 31, 2023 was USD 7.72 M, a -19.70% change year over year.
  • Suzhou Zelgen Biopharmaceuticals Co., Ltd. Depreciation And Amortization for the year ending December 31, 2022 was USD 9.62 M, a 20.36% change year over year.
  • Suzhou Zelgen Biopharmaceuticals Co., Ltd. Depreciation And Amortization for the year ending December 31, 2021 was USD 7.99 M, a 50.22% change year over year.
  • Suzhou Zelgen Biopharmaceuticals Co., Ltd. Depreciation And Amortization for the year ending December 31, 2020 was USD 5.32 M, a 12.24% change year over year.
Key Data
Date Depreciation And Amortization Dividends Paid Common Stock Issued Common Stock Repurchased